Regeneron

News

Sanofi's RA drug Kevzara approved in Europe

Sanofi’s next-generation rheumatoid arthritis drug Kevzara has been approved in Europe, giving a new option for patients who are intolerant to other treatments.

News

Novartis next generation eye drug outperforms Eylea

Brolucizumab could offer quarterly dosing schedule.

News

Sanofi/Regeneron PCSK9 lowers cholesterol in diabetes patien...

Companies awaiting CV outcomes trial, and court decision in patent case

News

Sanofi, Regeneron aim to undercut rivals with new RA drug

New drug will be sold at around 30% discount to rivals.

News

Regeneron and Inovio to aim immunotherapy at hard-to-treat b...

Regeneron is to collaborate with Inovio to investigate a three-way immunotherapy combination against glioblastoma multiforme (GBM), an aggressive and hard-to-treat brain tumour.

News